Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hereditary Sensory and Autonomic Neuropathies × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Head & Neck 1

Conditions

Lymphoma 2 Primary Myelofibrosis 1 Polycythemia Vera 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Chordoma 1 Advanced Solid Tumors 1

Interventions

tanezumab 1 Sirolimus 1 Panobinostat 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

National Cancer Centre, Singapore

Phase 1 Unknown

Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡